- Home
- SBFM vs NBY Comparison
SBFM vs NBY Comparison
Compare SBFM & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- NBY
- Stock Information
- Founded
- SBFM 2006
- NBY 2000
- Country
- SBFM United States
- NBY United States
- Employees
- SBFM N/A
- NBY N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- NBY
- Sector
- SBFM Health Care
- NBY
- Exchange
- SBFM Nasdaq
- NBY Nasdaq
- Market Cap
- SBFM 3.7M
- NBY 3.3M
- IPO Year
- SBFM N/A
- NBY 2007
- Fundamental
- Price
- SBFM $2.75
- NBY $0.53
- Analyst Decision
- SBFM Strong Buy
- NBY Strong Buy
- Analyst Count
- SBFM 1
- NBY 1
- Target Price
- SBFM $15.00
- NBY $0.85
- AVG Volume (30 Days)
- SBFM 1.8M
- NBY 77.8K
- Earning Date
- SBFM 11-05-2024
- NBY 11-07-2024
- Dividend Yield
- SBFM N/A
- NBY N/A
- EPS Growth
- SBFM N/A
- NBY N/A
- EPS
- SBFM N/A
- NBY N/A
- Revenue
- SBFM $32,959,491.00
- NBY $13,844,000.00
- Revenue This Year
- SBFM $86.70
- NBY N/A
- Revenue Next Year
- SBFM $126.76
- NBY $26.04
- P/E Ratio
- SBFM N/A
- NBY N/A
- Revenue Growth
- SBFM 61.94
- NBY 15.40
- 52 Week Low
- SBFM $2.11
- NBY $0.36
- 52 Week High
- SBFM $608.00
- NBY $10.15
- Technical
- Relative Strength Index (RSI)
- SBFM 47.83
- NBY 35.25
- Support Level
- SBFM $2.51
- NBY $0.52
- Resistance Level
- SBFM $2.82
- NBY $0.58
- Average True Range (ATR)
- SBFM 0.29
- NBY 0.03
- MACD
- SBFM -0.02
- NBY -0.00
- Stochastic Oscillator
- SBFM 22.34
- NBY 11.56
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.